WW
CRL icon

Waterfront Wealth’s Charles River Laboratories CRL Stock Holding History

Waterfront Wealth’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,701
Closed -$562K – 272
2025
Q2 		$562K Sell
3,701
-152
-4% -$20.3K 0.13% 183
2025
Q1 		$580K Buy
3,853
+368
+11% +$61.7K 0.14% 174
2024
Q4 		$643K Sell
3,485
-310
-8% -$59.7K 0.16% 167
2024
Q3 		$704K Buy
3,795
+84
+2% +$17.5K 0.17% 163
2024
Q2 		$767K Buy
3,711
+90
+2% +$20.4K 0.21% 148
2024
Q1 		$823K Buy
+3,621
New +$865K 0.23% 139

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Waterfront Wealth's CRL Position: Q3 2025 in Review

Waterfront Wealth sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 3,701 shares — an estimated $562K sold.

Waterfront Wealth first reported a position in CRL in Q1 2024 and held it in 6 quarters. The position peaked at $823K in Q1 2024. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Waterfront Wealth reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Waterfront Wealth sold 3,701 Charles River Laboratories shares in Q3 2025, an estimated $562K.
  • Waterfront Wealth first reported a position in Charles River Laboratories in Q1 2024 and held it in 6 quarters.
  • Waterfront Wealth's Charles River Laboratories position peaked at $823K in Q1 2024.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Waterfront Wealth's 13F filing for Q3 2025, filed 6 Nov 2025.